Research Article
The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose
Table 5
Pre- and postintervention outcomes in participants with impaired fasting glucose in the control group in a quasi-experimental intervention study.
| | Mean ± SD | t-test | value (paired t-test) |
| Fasting blood glucose (mmol/L) | Pre | 6.26 ± 0.99 | −0.988 | 0.332 | Post | 6.39 ± 1.08 | Total cholesterol (mmol/L) | Pre | 5.24 ± 0.95 | 1.039 | 0.308 | Post | 5.13 ± 1.03 | High-density lipoprotein (mmol/L) | Pre | 1.27 ± 0.26 | 0.197 | 0.845 | Post | 1.26 ± 0.27 | Low-density lipoprotein (mmol/L) | Pre | 3.38 ± 0.84 | 1.922 | 0.065 | Post | 3.13 ± 1.07 | Triglycerides (mmol/L) | Pre | 1.35 ± 0.88 | −0.411 | 0.681 | Post | 1.35 ± 1.26 | Body mass index (kg/m2) | Pre | 29.42 ± 5.38 | −1.418 | 0.167 | Post | 29.55 ± 5.39 | Systolic blood pressure (mm/Hg) | Pre | 134.12 ± 12.50 | 1.713 | 0.098 | Post | 131.00 ± 13.30 | Diastolic blood pressure (mm/Hg) | Pre | 83.07 ± 9.67 | −0.056 | 0.959 | Post | 83.14 ± 12.05 |
|
|
Median ± IQR. Wilcoxon signed-ranks test. |